Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
10.80
-0.11 (-1.01%)
May 22, 2026, 9:30 AM EDT - Market open

Climb Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8.3635.6987.2393.1143.5946.92
Short-Term Investments
101.2165.463.6913.6979.9889.56
Cash & Short-Term Investments
109.56101.08150.92106.8123.57136.48
Cash Growth
11.73%-33.02%41.31%-13.57%-9.46%566.18%
Other Current Assets
3.844.773.953.4610.8311.77
Total Current Assets
113.4105.85154.87110.26134.39148.25
Net Property, Plant & Equipment
0.70.790.690.20.47-
Long-Term Investments
36.7459.5761.61--24.92
Other Long-Term Assets
1.531.530.020.020.130.07
Total Assets
152.37167.74217.19110.47134.99173.24
Accounts Payable
0.862.270.710.070.751.4
Accrued Expenses
2.954.464.072.435.054.63
Current Portion of Leases
0.260.260.160.330.3-
Total Current Liabilities
4.076.984.932.836.16.03
Long-Term Leases
0.220.290.380.020.18-
Other Long-Term Liabilities
---0.02-0.01
Total Long-Term Liabilities
0.220.290.380.040.180.01
Total Liabilities
4.297.275.312.876.286.04
Common Stock
0.010.010.01000
Additional Paid-in Capital
451.37449.76441.73263.58249.93242.94
Accumulated Other Comprehensive Income
0.160.440.02-0-0.36-0.12
Retained Earnings
-303.45-289.73-229.88-155.98-120.86-75.62
Total Common Shareholders' Equity
148.09160.48211.88107.6128.72167.2
Shareholders' Equity
148.09160.48211.88107.6128.72167.2
Total Liabilities & Equity
152.37167.74217.19110.47134.99173.24
Total Debt
0.480.540.530.350.480
Net Cash (Debt)
109.09100.54150.39106.45123.09136.48
Net Cash Growth
8.50%-33.15%41.28%-13.52%-9.81%566.18%
Net Cash Per Share
1.601.483.123.944.6811.13
Book Value
148.09160.48211.88107.6128.72167.2
Book Value Per Share
2.182.374.403.984.8913.64
Tangible Book Value
148.09160.48211.88107.6128.72167.2
Tangible Book Value Per Share
2.182.374.403.984.8913.64
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q